CONFERENCES

      International Society for Aerosols in Medicine Congress

      International Society for Aerosols in Medicine Congress (ISAM) is a biennial event that focuses on the latest developments in aerosol technologies and their impact on human health, with topics ranging from pulmonary diseases to regulatory planning. The conference is aimed at clinicians, respiratory health care professionals, critical care professionals, aerosol scientists, inhalation toxicologists and engineers, pharmaceutical scientists, and product development and regulatory experts, and provides a forum for sharing knowledge and collaborating on advancements in aerosol technologies.

      ISAM 2017

      Date

      Jun 03, 2017 - Jun 07, 2017

      Location

      Sante Fe, USA

      The 21st Congress of the International Society of Aerosols in Medicine offers a platform for discussions between partners from different disciplines and locations. At this event, PMI scientists present thr research on the suitability of the Vitrocell®24/48 aerosol exposure system for in vivo toxicology assessments.  

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.